Ligilactobacillus salivarius LS01™ (DSM 22775) (formerly Lactobacillus salivarius)
Dermatology
gut-skin axis
Supports healthy, clear skin
Improves the Quality of Life in subjects with Atopic Dermatitis
Supports gut barrier integrity
Promotes healthy inflammatory responses to C. acnes
Inhibits pathogenic S. aureus
1) 2) 3) 2 billion CFU (FLORATOPIC®)
Blend
Finished dosage form
1) Drago L. et al. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int J Immunopathol Pharmacol. 2011; 24(4):1037-48. DOI: 10.1177/039463201102400421
2) Drago L. et al. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012; 46 Suppl:S56-63. DOI: 10.1097/MCG.0b013e318265ef38
3) Niccoli A. et al. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J Clin Gastroenterol. 2014; 48 Suppl:S34-36. DOI: 10.1097/MCG.0000000000000233
For information on blends containing LS01™, see the following Blends and Products pages:
- BIFIASTHM®
- BIFIDERM®
- FLORATOPIC®
- PROBIAL® DERM
a) Drago L. et al. Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes. 2010; 3:44. DOI: 10.1186/1756-0500-3-44
b) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
Allergy & Immunology
Respiratory/ Immune health
Supports a healthy immune response [in vitro]
Blend
Finished dosage form
a) Drago L. et al. Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics. Allergy Asthma Immunol Res. 2015 Jul;7(4):409-13. doi: 10.4168/aair.2015.7.4.409.
For information on blends containing LS01™, see the Blends and Products pages listed above.
Gastroenterology
GUT DYSBIOSIS
Inhibits a range of pathogens [in vitro]
Blend
Finished dosage form
a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
b) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
For information on blends containing LS01™, see the Blends and Products pages listed above.
Neurology
Neuro-immune Health
Supports healthy immune and antioxidant responses in blood cells [in vitro]
Single strain
Blend
Finished dosage form
a) Magistrelli L. et al. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front Immunol. 2019 May 7;10:969. doi: 10.3389/fimmu.2019.00969
For information on blends containing LS01™, see the Blends and Products pages listed above.
